Northland Capital Markets Maintains Outperform on BioLife Solns, Raises Price Target to $28
Portfolio Pulse from Benzinga Newsdesk
Northland Capital Markets has maintained an Outperform rating on BioLife Solutions (NASDAQ:BLFS) and raised the price target from $26 to $28.
August 09, 2024 | 5:37 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Northland Capital Markets has maintained an Outperform rating on BioLife Solutions and raised the price target from $26 to $28.
The raised price target and maintained Outperform rating from Northland Capital Markets are positive signals for BioLife Solutions, likely leading to increased investor confidence and a potential short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100